Investigating diagnostic sequencing techniques for CADASIL diagnosis.
P J Dunn1, N Maksemous1, R A Smith1
1Genomics Research Centre, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
Human Genomics
|January 10, 2020
Summary
Next-generation sequencing (NGS) panels significantly improve the detection of NOTCH3 gene mutations for diagnosing cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a rare small vessel disease.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a genetic small vessel disease.
- NOTCH3 gene mutations are the primary cause of CADASIL.
- Genetic diagnostic testing for CADASIL has evolved over time.
Purpose of the Study:
- To evaluate the diagnostic efficacy of different genetic sequencing technologies for CADASIL.
- To compare Sanger sequencing, targeted next-generation sequencing (NGS) panels, and whole exome sequencing (WES) for NOTCH3 mutation detection.
- To analyze mutation detection rates and characteristics over a long period.
Main Methods:
- Analysis of 680 patient samples and 764 genetic tests.
- Utilized Sanger sequencing, a targeted NGS gene panel (including NOTCH3 exons), and WES.
- Stratified mutation data by detection method, exon number, pathogenicity, and novelty.
Main Results:
- Overall mutation detection rate was 14.7% (100/680 patients).
- NGS custom panel achieved a higher mutation detection rate (15.8%) compared to Sanger sequencing (10.8%).
- WES identified a likely non-NOTCH3 pathogenic variant.
Conclusions:
- Next-generation sequencing (NGS) technologies, particularly custom panels, enhance the diagnostic yield for NOTCH3 mutations in CADASIL.
- The study highlights the evolution and improvement of genetic testing methodologies for CADASIL.
- Accurate genetic diagnosis is crucial for understanding and managing CADASIL.
Related Concept Videos
Sanger Sequencing
772.4K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
772.4K
RNA-seq
11.6K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
11.6K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
325
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
325


